BIOCAUSE HEILEN PHARMA: Hydrochloride of Methoxychlorpromazine has received approval for the listing application of chemical raw materials

Zhitong
2025.09.16 08:01
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA announced that the company recently received the "Approval Notice for the Market Application of Chemical Raw Materials" issued by the National Medical Products Administration for Metoclopramide Hydrochloride. Metoclopramide Hydrochloride is a dopamine receptor antagonist primarily used to relieve symptoms of nausea and vomiting, and it can also promote gastrointestinal motility to improve issues such as dyspepsia and delayed gastric emptying

According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA (301211.SZ) announced that the company recently received the "Approval Notice for the Market Application of Chemical Raw Materials" for Metoclopramide Hydrochloride issued by the National Medical Products Administration. Metoclopramide Hydrochloride is a dopamine receptor antagonist primarily used to relieve symptoms of nausea and vomiting, and it can also promote gastrointestinal motility to improve issues such as dyspepsia and delayed gastric emptying

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.